Clinical Evaluation of Efficacy of Unani Formulation in Ovulation Induction in Anovulatory Infertility
Keywords:
ovulation, folliculogenesis, Withania somnifera, conception rateAbstract
Anovulation is responsible for 30–40% of infertility. The aim of the present study was to evaluate the efficacy of unani formulation in ovulation induction. A standard controlled randomized single blind study was undertaken at Gynaecology department, National Institute of Unani Medicine Hospital, Bangalore. Patients of anovulatory infertility with menstrual irregularities and polycystic ovarian disease in the age group of 20-40 years were randomly allocated to test (n=20) and control (n=10) groups. Patients with primary ovarian failure, thyroid dysfunction, hyperprolactinemia, systemic illnesses and malignancy were excluded. In test group, Unani formulation consisting of Withania somnifera, Anogeissus latifolia, Nymphaea alba and Barleria prionitis was administered in powdered form 12 gm (in two divided doses) daily from 5th day of menstrual cycle for 5 days along with milk for three consecutive cycles. In control group clomiphene citrate in 50 mg dose was administered once daily for the same duration. Primary outcome measure was ovulation. Secondary outcome measure was conception rate. Results were analysed using Student‘t’test, Chi-square (χ2) and Fisher Exact test. Ovulatory rate was 40%, 35.3% and 68.8% in 1st, 2nd and 3rd cycle in test group, while in control group it was 60% in 1st cycle and 55.6% in each 2nd and 3rd cycle, respectively. Conception rate was 10% and 18.8% in 1st and 3rd cycle in test group, while in control group it was only 10% in 1st cycle during treatment. The effect of unani formulation was comparable with that of control drug; therefore it can be used as an alternate therapy for ovulation induction.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is notpublished already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
_______________
We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |